Literature DB >> 9774224

Diminution of contractile response by kappa-opioid receptor agonists in isolated rat ventricular cardiomyocytes is mediated via a pertussis toxin-sensitive G protein.

H Wenzlaff1, B Stein, H Teschemacher.   

Abstract

Opioids directly decrease the contractile response of isolated ventricular cardiomyocytes to electrical stimulation. To investigate whether these effects are mediated via GTP-binding G(i/o) proteins we examined the influence of pertussis toxin on the effects of the kappa-opioid receptor agonist trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benz eneacetamide (U-50,488) methanesulphonate and on the as yet undescribed effects of the opioid peptide dynorphin A (1-8) on contraction. In isolated, electrically driven, rat ventricular cardiomyocytes both agents concentration dependently reduced cell shortening within 15 min, decreasing the contractile response by 79+/-4% (n=5) and 62+/-2% (n=6) of control values at maximal effective concentrations of 10 microM (U-50,488) and 1 microM [dynorphin A (1-8)], respectively. Pertussis toxin pre-treatment (200 ng/ml; 4.5-5 h) completely abolished the effects of U-50,488 and dynorphin A (1-8) on the contractile response, indicating that these effects are mediated via G(i/o) proteins. In addition, the non-selective opioid receptor antagonist (-)-naloxone and the kappa-opioid receptor antagonist nor-binaltorphimine antagonized the effects of U-50,488 and dynorphin A (1-8) on the contractile response. Furthermore, the mu- and delta-opioid receptor agonist (D-Ala2, D-Leu5)-enkephalin (DADLE) had no effects on contraction. These results indicate that the decrease in cell shortening is due to stimulation of kappa-opioid receptors. The direct effect of kappa-opioid receptor agonists on the contractile response thus represents an additional mechanism for decreasing cardiac contractility, besides the M-cholinoceptor- or adenosine receptor-mediated pathway. It is conceivable that increased release of endogenous dynorphins from the heart during hypoxia may protect the heart in a similar manner to adenosine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774224     DOI: 10.1007/pl00005265

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  4 in total

Review 1.  A story of two ACEs.

Authors:  Ursula Danilczyk; Urs Eriksson; Michael A Crackower; Josef M Penninger
Journal:  J Mol Med (Berl)       Date:  2003-03-28       Impact factor: 4.599

2.  Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation.

Authors:  Craig Bolte; Gilbert Newman; Jo El J Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

Review 3.  Structure, evolutionary conservation, and functions of angiotensin- and endothelin-converting enzymes.

Authors:  Nathalie Macours; Jeroen Poels; Korneel Hens; Carmen Francis; Roger Huybrechts
Journal:  Int Rev Cytol       Date:  2004

4.  Morphine enhances doxorubicin-induced cardiotoxicity in the rat.

Authors:  Lisa Drange Hole; Terje Hjalmar Larsen; Kjell Ove Fossan; Fredrik Limé; Jan Schjøtt
Journal:  Cardiovasc Toxicol       Date:  2014-09       Impact factor: 3.231

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.